Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin ’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study
ConclusionRasburicase was well tolerated and effective in controlling hyperuricemia in Chinese pediatric patients with NHL and AL.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research
More News: Acute Leukemia | Children | China Health | Drugs & Pharmacology | Japan Health | Leukemia | Lymphoma | Pediatrics | Study